Literature DB >> 20930448

Efficacy of rituximab monotherapy for an elderly hemodialysis patient with primary cardiac lymphoma.

Yasuyoshi Morita1, Mitsuhiro Matsuda, Terufumi Yamaguchi, Mika Sakaguchi, Shinya Rai, Yoshitaka Kanai, Chikara Hirase, Kazunobu Kawanishi, Junichi Miyatake, Takahiro Shimada, Yoichi Tatsumi, Takashi Ashida, Yasuhiro Maeda, Akihisa Kanamaru.   

Abstract

We report a case of primary cardiac lymphoma (PCL) occurring in a 76-year-old man during maintenance hemodialysis. Chest computed tomography (CT) revealed a tumor with pericardial effusion in the left ventricular posterior wall. Cytological examination of the pericardial fluid revealed monotonous lymphoid cells positive for B-cell markers, and clonal immunoglobulin heavy chain gene rearrangement was detected, indicating B-cell lymphoma. Rituximab monotherapy was administered biweekly at the therapeutic level on hemodialysis. The follow-up chest CT showed tumor disappearance with pericardial fluid after two courses of therapy. Rituximab monotherapy was effective for an elderly hemodialysis patient with PCL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930448     DOI: 10.2169/internalmedicine.49.4018

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  The diagnosis of primary cardiac lymphoma was facilitated by computed tomographic coronary angiography.

Authors:  Naohiro Nose; Tetsuya So; Atsushi Sekimura; Takeaki Miyata; Takashi Yoshimatsu; Yasuji Matsuno
Journal:  J Surg Case Rep       Date:  2014-12-19

2.  Rituximab use for lymphoplasmacytic lymphoma during continuous renal replacement therapy.

Authors:  Marco Simões; Marisa Miranda; José Carda; Anália Carmo; Paulo Martins
Journal:  Rev Bras Ter Intensiva       Date:  2019-06-27

3.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.